Search the Newsreel

United States Antimony Corp. (UAMY) Fundamental & Financial Data

This article provides fundamental and financial data for United States Antimony Corp. (UAMY), including its current stock price, market capitalization, P/E ratio, and recent news. As of the update, UAMY's stock was trading at $5.49, down 5.99%, with a market cap of $865.4M and …

Harmony Biosciences to report Q2 2026 results on August 4

Harmony Biosciences Holdings, Inc. will announce its Q2 2026 financial results on Tuesday, August 4, 2026, before market open. A conference call and webcast will be held at 8:30 a.m. ET to discuss these results, with investors able to participate via specific dial-in numbers …

Harmony Biosciences will host a live Q2 results webcast on Aug. 4

Harmony Biosciences (Nasdaq: HRMY) announced it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, before the U.S. market opens. The company will also host a conference call and live webcast for investors and analysts at 8:30 a.m. ET on …

Mony Group H1 Earnings Call Highlights

This article first appeared on GuruFocus. Revenue: Increased by 6% on a like-for-like basis to GBP227 million. Adjusted EBITDA: Up 3% to GBP76 million. Basic and Adjusted EPS: Expanded by 4% and 5%, respectively. SuperSaveClub Members: Increased by 1 million, totaling 2.5 million members. …

Harmony Gold Mining Reports Fatal Incident at TauTona Shaft

H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

H.C. Wainwright analyst Patrick Trucchio has reiterated a Buy rating on Harmony Biosciences Holdings Inc. (HRMY). The analyst also maintained a price target of $55.00 for the company's stock. This article is behind a paywall and requires a premium subscription to read the full …

H.C. Wainwright reiterates Harmony Biosciences stock rating on demand beat

H.C. Wainwright reiterated a Buy rating and a $55 price target for Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) after the company announced stronger-than-expected second-quarter revenue. The beat was attributed to increased demand, leading H.C. Wainwright to modestly raise its full-year 2026 net product revenue estimate …

Harmony Bio drops after CFO exit

Harmony Bio's stock fell sharply following the unexpected departure of its Chief Financial Officer. The company has not yet named a successor, leading to investor uncertainty. This executive change raises questions about the company's financial stability and future strategic direction.

United States Antimony Stock Dips as Gold and Silver Drop Amid Strong Dollar

United States Antimony (UAMY) shares are declining due to a drop in gold and silver prices, which are under pressure from escalating Middle East conflict. The conflict is driving up oil prices and Treasury yields, fanning inflation anxieties, and strengthening the dollar, making gold …

HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition

Harmony Biosciences (HRMY) announced strong preliminary Q2 2026 net product revenues of $261 million for its drug Wakix, a 30% year-over-year increase, and reiterated its full-year guidance of $1.0 billion to $1.04 billion. Concurrently, the company announced the departure of CFO Glenn Reicin, with …

Harmony Biosciences reaffirms 2026 net revenue outlook of $1 billion-$1.04 billion

Harmony Biosciences has reaffirmed its net revenue guidance for WAKIX in 2026, projecting between $1 billion and $1.04 billion. This outlook is supported by strong preliminary second-quarter WAKIX net revenue of approximately $261 million, marking a 30% year-over-year increase and a 21% rise from …

Matrimony.com profit declines 24.5% to ₹34.17 crore in FY26

Harmony Gold Mining Co. Ltd (HMY) Q4 2025 Earnings Report - Results, Call & Slides

Harmony Gold Mining (HMY) reported its Q4 2025 earnings, meeting EPS expectations at $0.57 while beating revenue forecasts with $2.17 billion, a 31.74% year-over-year increase. The company's actual revenue surpassed the expected $2.03 billion by $138.43 million. The earnings call took place on Thursday, …

United States Antimony Stock Dips as Gold, Silver and Dollar Rise

United States Antimony (UAMY) shares fell by 11.99% as gold, silver, and other precious metals declined. This drop is attributed to escalating Middle East tensions, particularly between US and Iranian forces, which have led to surging oil prices, rising Treasury yields, and a stronger …

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition

Harmony Biosciences announced record preliminary, unaudited net product revenue of approximately $261 million for WAKIX® in Q2 2026, a 30% year-over-year increase, and reaffirmed its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion. The company also announced the departure of …

Harmony Biosciences reports record Q2 WAKIX sales of $261M

Harmony Biosciences Holdings, Inc. announced record preliminary, unaudited second-quarter 2026 net product revenue of $261 million for WAKIX, representing a 30% year-over-year increase. The company reaffirmed its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion, driven by strong demand and …

Harmony Biosciences Announces CFO Transition as Glenn Reicin Steps Down

Harmony Biosciences announced that CFO Glenn Reicin has stepped down, effective July 16, 2026, to pursue other opportunities. Stephen Mollichella, SVP and controller, has been appointed interim principal financial officer. The company also reported record preliminary second-quarter revenue of approximately $261 million for WAKIX® …

GUIDANCE: (HRMY) Harmony Biosciences Expects Q2 Wakix Net Product Revenue About $261M

Harmony Biosciences (HRMY) announced it expects its second-quarter Wakix net product revenue to be approximately $261 million. This projection indicates continued strong performance for their primary product. The financial guidance provides a positive outlook for the company's Q2 results.

Harmony Biosciences Announces Preliminary Q2 Revenue, CFO Transition — Says Executive’s Departure Not Due To Any Disagreement

Harmony Biosciences reported preliminary second-quarter net product revenue for WAKIX of approximately $261 million, a new record, and reaffirmed its full-year 2026 revenue guidance of $1.0 billion to $1.04 billion. Concurrently, the company announced that CFO Glenn Reicin stepped down, with Stephen Mollichella appointed …

Harmony Bio stock drops after CFO exit (HRMY:NASDAQ)

Harmony Biosciences (HRMY) stock declined following the resignation of its Chief Financial Officer, Glenn Reicin, who left to pursue other career opportunities. Stephen Mollichella, the SVP and Controller, has been appointed as the Interim Principal Financial Officer to oversee financial operations for the rare …

Harmony Biosciences (HRMY) AGM 2026 Summary

Harmony Biosciences held its 2026 Annual General Meeting (AGM) on May 18, 2026, where four Class 3 directors were nominated for election, and shareholders were asked to vote on the election of directors, ratification of Deloitte & Touche LLP as independent auditor, and a …

Harmony Biosciences (HRMY) Q4 2025 earnings summary

Harmony Biosciences reported strong Q4 2025 results with net product revenue of $243.8M, a 21% year-over-year increase, and full-year revenue of $868.5M. The company provided 2026 WAKIX net revenue guidance of $1B–$1.04B, anticipating blockbuster status, and is advancing a late-stage pipeline with five Phase …

Jack-in-the-Stox: U.S. Antimony and the Return of Industrial Reality

This article discusses the rising strategic importance of antimony, moving from an obscure metal to a critical material due to Chinese export restrictions. Author Jack Lifton emphasizes that while many companies are exploring antimony mining, U.S. Antimony stands out because it already possesses established …

Harmony Gold Mining Co. Ltd. Stock 12‑Month Price Target Raised to ZAC 39291.17, Implies 55% Upside

Harmony Gold Mining Co. Ltd.'s average 12-month price target has been increased to ZAC 39291.17 from ZAC 38577.56, based on estimates from 9 analysts. This updated target suggests a potential upside of approximately 55% from the July 14 closing price. The consensus rating for …

US Antimony contracts AI firm for Los Juarez silver mine project

United States Antimony Corporation (NYSE:UAMY) has hired an artificial intelligence firm to analyze historical geological data for its inactive Los Juarez Silver Mine in Mexico, aiming to significantly reduce data processing timelines. This strategic move is intended to evaluate the mine's potential given current …

United States Antimony Announces Utilization of AI Technology into Certain Mining Projects

United States Antimony Corporation (USAC) has contracted an AI firm to incorporate artificial intelligence technology into its mining projects, starting with the Los Juarez Silver Mine in Mexico. The goal is to reduce risk, expedite production, and leverage historical geological data to enhance probabilistic …

US Antimony Reprocesses Years of Mine Data in Weeks With AI

United States Antimony (NYSE: UAMY) has contracted an AI firm specializing in hard rock mining to reprocess historical data for its Los Juarez Silver Mine project in Mexico. This initiative aims to reduce risk, accelerate production decisions, and "high grade" the asset's potential by …

MONY Forecast — Price Target — Prediction for 2027

Tech Query: Mahindra & Mahindra (M&M), Indian Overseas Bank (IOB), Matrimony.com, EID Parry India - What is the outlook? Where are these stocks headed?

Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?

Harmony Gold Share Price 2026: Technical Analysis, Valuation Metrics, and Investment Outlook

Zacks Industry Outlook Highlights Franco-Nevada, Harmony Gold, Novagold Resources, DRDGOLD and Idaho Strategic Resources

Matrimony.com Q4 PAT Rises 18.9%; Profit To Double

Harmony Gold Mining Co Ltd (HMY) Shares Fall 9.6% -- What GF Sco

Matrimony.com Consolidated March 2026 Net Sales at Rs 121.79 crore, up 12.44% Y-o-Y

Matrimony.com posts Rs 117 Cr revenue and Rs 10 Cr profit in Q4 FY26